OBJECTIVE: Most estimates of physical activity (PA) patterns in systemic lupus erythematosus (SLE) are based on subjective self-report measures prone to error. The aims of this study were to obtain objective measurements of PA using an accelerometer and estimates of energy expenditure based on the self-reported International Physical Activity Questionnaire (IPAQ), and to describe their relationship. METHODS: The Activity in Lupus To Energize and Renew study, a cross-sectional study of PA, included 129 persons with SLE. Accelerometer measures >7 days included total daily activity counts and minutes of moderate-vigorous PA (MVPA). Each person completed the IPAQ via telephone interview. Spearman's correlations (r) and 95% confidence intervals (95% CIs) assessed associations between accelerometer and IPAQ. RESULTS: Daily PA means and SDs from accelerometer measures were 502,910 ± 118,755 for total daily activity counts and 40 ± 30 minutes for MVPA. The median (interquartile range) MET minutes/day for IPAQ intensities were: 400 (159-693) for total; 83 (26-184) for walking; and 231 (77-514) for MVPA, and domains were: 0 (0-73) for work; 28 (0-85) for active transportation; 77 (26-231) for domestic and garden; and 57 (0-213) for leisure. Associations between accelerometer measures and IPAQ were 1) total daily count versus IPAQ total: r = 0.21 (95% CI 0.03, 0.37) and 2) MVPA versus IPAQ moderate-vigorous: r = 0.16 (95% CI - 230.02, 0.33). CONCLUSION: Accelerometer measures and IPAQ energy expenditure estimates were moderately correlated. IPAQ provided descriptive PA data, whereas accelerometers captured all daily activities, which can help assess guideline attainment. The choice of IPAQ versus accelerometer measure should include considering the purpose for which PA is measured.
OBJECTIVE: Most estimates of physical activity (PA) patterns in systemic lupus erythematosus (SLE) are based on subjective self-report measures prone to error. The aims of this study were to obtain objective measurements of PA using an accelerometer and estimates of energy expenditure based on the self-reported International Physical Activity Questionnaire (IPAQ), and to describe their relationship. METHODS: The Activity in Lupus To Energize and Renew study, a cross-sectional study of PA, included 129 persons with SLE. Accelerometer measures >7 days included total daily activity counts and minutes of moderate-vigorous PA (MVPA). Each person completed the IPAQ via telephone interview. Spearman's correlations (r) and 95% confidence intervals (95% CIs) assessed associations between accelerometer and IPAQ. RESULTS: Daily PA means and SDs from accelerometer measures were 502,910 ± 118,755 for total daily activity counts and 40 ± 30 minutes for MVPA. The median (interquartile range) MET minutes/day for IPAQ intensities were: 400 (159-693) for total; 83 (26-184) for walking; and 231 (77-514) for MVPA, and domains were: 0 (0-73) for work; 28 (0-85) for active transportation; 77 (26-231) for domestic and garden; and 57 (0-213) for leisure. Associations between accelerometer measures and IPAQ were 1) total daily count versus IPAQ total: r = 0.21 (95% CI 0.03, 0.37) and 2) MVPA versus IPAQ moderate-vigorous: r = 0.16 (95% CI - 230.02, 0.33). CONCLUSION: Accelerometer measures and IPAQ energy expenditure estimates were moderately correlated. IPAQ provided descriptive PA data, whereas accelerometers captured all daily activities, which can help assess guideline attainment. The choice of IPAQ versus accelerometer measure should include considering the purpose for which PA is measured.
Authors: Søren Brage; Niels Wedderkopp; Paul W Franks; Lars Bo Andersen; Karsten Froberg Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: G Plasqui; A Boonen; P Geusens; E J Kroot; M Starmans; S van der Linden Journal: Arthritis Care Res (Hoboken) Date: 2012-01 Impact factor: 4.794
Authors: Mary A Mahieu; Grace E Ahn; Joan S Chmiel; Dorothy D Dunlop; Irene B Helenowski; Pamela Semanik; Jing Song; Susan Yount; Rowland W Chang; Rosalind Ramsey-Goldman Journal: Rheumatol Int Date: 2018-01-04 Impact factor: 2.631
Authors: M A Mahieu; G E Ahn; J S Chmiel; D D Dunlop; I B Helenowski; P Semanik; J Song; S Yount; R W Chang; R Ramsey-Goldman Journal: Lupus Date: 2016-02-10 Impact factor: 2.911
Authors: Pablo Morillas-de-Laguno; José A Vargas-Hitos; Antonio Rosales-Castillo; Luis Manuel Sáez-Urán; Cristina Montalbán-Méndez; Blanca Gavilán-Carrera; Carmen Navarro-Mateos; Pedro Acosta-Manzano; Manuel Delgado-Fernández; José M Sabio; Norberto Ortego-Centeno; José L Callejas-Rubio; Alberto Soriano-Maldonado Journal: PLoS One Date: 2018-04-25 Impact factor: 3.240